Home Tags Pharmaceutical
Wall Street thinks CBD could be a $16 billion industry by 2025. Here’s what the cannabis compound does to your brain and body.
Cannabidiol, or CBD, is a compound in marijuana that's not linked with a high. Here's what we know about its mental and physical effects.
Elizabeth Warren is picking a fight with the billionaire family that is accused of deceptively marketing opioids like OxyContin
Warren targeted the Sacklers while laying out her $100 billion plan to fight the opioid crisis, which she would fund with her "ultra-millionaire" tax.
Elizabeth Warren proposes paying for an ambitious plan to spend $100 billion fighting the opioid crisis with her new tax on the ultra-rich
The money would support a whole range of services — including early intervention, addiction treatment, mental-health care, and housing support.
Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.
The cost of gene therapies will put a huge financial strain on the US health system as new products become available to treat more common diseases.
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.
GE Healthcare just filed a confidential IPO, kickstarting a spin-off that would create one of the world’s biggest health giants
The industrial conglomerate is said to be working with Goldman Sachs, Bank of America, Citigroup, JPMorgan, and Morgan Stanley on its IPO plans.
Opioid overdose deaths are highest in places where pharma spends the most on marketing, a new study finds
Researchers at the University of Pittsburgh launched a study to figure out if there's a link between the money that drugmakers spend on opioid marketing and drug-related deaths.
On Thursday, pharma giant Eli Lilly and Co. announced positive results in a mid-stage trial for its experimental new diabetes drug. The company's stock was up 3% in afternoon trading.
Pfizer’s long-serving CEO, Ian Read, is standing down and being replaced by his chief operating officer
Read, who has been at the helm of the firm since 2010, will stand down on January 1, the company announced Monday. He will be replaced by Pfizer's chief operating officer, Albert Bourla.
A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it’s eyeing the pharma industry
Boston-based startup Ginkgo Bioworks will use Cronos' labs to produce synthetic marijuana compounds, many of which "have the potential to be valuable in a range of pharmaceutical applications."